London Loves Business, in its coverage of the study, reveals that since 2010, the pharmaceutical industry has been slapped with penalties amounting to $82.8 billion across more than 500 documented cases. These violations encompass issues such as disregarding drug and medical device safety standards, promoting medical products without proper authorization, breaching the False Claims Act, and a range of other transgressions.
Republican Senators James Lankford (Oklahoma) and Pete Ricketts (Nebraska) have introduced a bill that seeks…
New blue hues and flavors from top breeders have arrived. The post New Blueberry weed…
While there are many studies showing potential and promise for using various compounds in cannabis…
Trump's declaration of drug cartels as terrorist organizations and his war cry to ramp up…
A recent poll conducted by the University of Houston’s Hobby School of Public Affairs has…
Candies, Z, OGs, and more from Leafly’s senior editor. The post David Downs’ sickest weed…